Eddingpharm Investment. Information on valuation, funding, cap tables, investors, and executives for eddingpharm. Get information on funding, investors, industries, and more for eddingpharm.
Information on valuation, funding, cap tables, investors, and executives for eddingpharm. See eddingpharm company profile and funding data. Use the pitchbook platform to explore the full profile.
Information On Valuation, Funding, Cap Tables, Investors, And Executives For Eddingpharm.
Closed a $24 million series b financing. Eddingpharm will pay $75 million upfront and $300 million when the deal closes, which is expected to be late 2019 or early 2020. Eddingpharm forked over $375 million for the rights to sell ceclor and vancocin in china, as well as a manufacturing facility that makes the two medications.
Get Information On Funding, Investors, Industries, And More For Eddingpharm.
The prospectus shows that in november 2019, when eddingpharm last raised its financing, tigermed, yingke kyushu, and yongxiuguan jointly subscribed and made a surprise. Use the pitchbook platform to explore the full profile. Request a free trial log in
Amarin Corp Plc ($Amrn) And Eddingpharm Announced An Exclusive Agreement For Eddingpharm To Develop And Commercialize Vascepa® (Icosapent Ethyl) In The Territories Of.
Amarin corporation plc and eddingpharm, two pharmaceutical companies focused on the development and commercialization of innovative therapeutics, have announced an.
Images References :
Closed A $24 Million Series B Financing.
The two antibiotics are ceclor (cefaclor) and. Eddingpharm will pay $75 million upfront and $300 million when the deal closes, which is expected to be late 2019 or early 2020. Eddingpharm forked over $375 million for the rights to sell ceclor and vancocin in china, as well as a manufacturing facility that makes the two medications.
Get Information On Funding, Investors, Industries, And More For Eddingpharm.
Use the pitchbook platform to explore the full profile. Company profile page for eddingpharm investment co ltd including stock price, company news, executives, board members, and contact information Amarin corp plc ($amrn) and eddingpharm announced an exclusive agreement for eddingpharm to develop and commercialize vascepa® (icosapent ethyl) in the territories of.
Amarin Corporation Plc And Eddingpharm, Two Pharmaceutical Companies Focused On The Development And Commercialization Of Innovative Therapeutics, Have Announced An.
Information on valuation, funding, cap tables, investors, and executives for eddingpharm. See eddingpharm company profile and funding data. Request a free trial log in
The Prospectus Shows That In November 2019, When Eddingpharm Last Raised Its Financing, Tigermed, Yingke Kyushu, And Yongxiuguan Jointly Subscribed And Made A Surprise.
